Cardiac Monitoring Device Portfolio For Clinical Trials

Philips BioTel Research offers a comprehensive portfolio of cardiac monitoring devices, including both site-based equipment and patient-centric, at-home devices for decentralized approaches to cardiac safety monitoring in clinical trials. We have the industry’s most experienced and robust global distribution network. Our multiple airport-adjacent, professional logistics hubs process roughly 17,000 shipments per month.

We support all major cardiovascular testing modalities for clinical trials including ECG, event monitoring, blood pressure, and Holter monitoring, as well as ECHO and MUGA testing. The following information describes the key features of our cardiac monitoring devices.

Given the multiple monitoring options available, we recommend that you contact us for an initial consultation into your trial needs.